Search research articles
Contact Us
Filters
Showing results (1161-1170 of 1,776) with videos related to
Page
of 178
Sort By:
Cardiovascular Research
|
August 20, 2009
Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner
Adriana Barana, Irene Amorós, Ricardo Caballero, et al.
Medicina Oral, Patologia Oral Y Cirugia Bucal
|
August 17, 2010
Occular complications following dental local anesthesia
J-M Aguado-Gil, C Barona-Dorado, J-C Lillo-Rodríguez, et al.
Clinical Biochemistry
|
December 4, 2013
Intra-familiar discordant PKU phenotype explained by mutation analysis in three pedigrees
Roberta Trunzo, Rosa Santacroce, Giovanna D'Andrea, et al.
Stem Cell Research
|
June 22, 2024
Generation of iPSC lines and isogenic gene-corrected lines from two individuals with RPS19-mutated Diamond-Blackfan anemia syndrome
Maria Angeles Lillo Osuna, Lei Han, Jon P Connelly, et al.
Veterinary Surgery : VS
|
December 14, 2023
Laparoscopic resection of pancreatic masses in 12 dogs
Edoardo Poggi, Felipe J Lillo-Araya, David Garcia Rubio, et al.
The Journal of Biological Chemistry
|
January 12, 2002
Structure and mechanism of 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase. An enzyme in the mevalonate-independent isoprenoid biosynthetic pathway
Stéphane B Richard, Jean-Luc Ferrer, Marianne E Bowman, et al.
Nature Structural Biology
|
June 28, 2001
Structure of 4-diphosphocytidyl-2-C- methylerythritol synthetase involved in mevalonate- independent isoprenoid biosynthesis
S B Richard, M E Bowman, W Kwiatkowski, et al.
AIDS Patient Care and Stds
|
October 15, 2009
Cardiovascular risk assessment in antiretroviral-naïve HIV patients
Paolo Maggi, Tiziana Quirino, Elena Ricci, et al.
Cancer Chemotherapy and Pharmacology
|
May 19, 2011
Population pharmacokinetics of PM00104 (Zalypsis(®)) in cancer patients
Carlos Pérez-Ruixo, Belén Valenzuela, Carlos Fernández Teruel, et al.
Investigational New Drugs
|
May 8, 2015
First-in-human, phase I study of elisidepsin (PM02734) administered as a 30-min or as a 3-hour intravenous infusion every three weeks in patients with advanced solid tumors
Mark J Ratain, David Geary, Samir D Undevia, et al.
Page
of 178
Search research articles
Search
Showing results (1161-1170 of 1,776) with videos related to
Sort By:
Page
of 178
Cardiovascular Research
|
August 20, 2009
Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner
Adriana Barana, Irene Amorós, Ricardo Caballero, et al.
Medicina Oral, Patologia Oral Y Cirugia Bucal
|
August 17, 2010
Occular complications following dental local anesthesia
J-M Aguado-Gil, C Barona-Dorado, J-C Lillo-Rodríguez, et al.
Clinical Biochemistry
|
December 4, 2013
Intra-familiar discordant PKU phenotype explained by mutation analysis in three pedigrees
Roberta Trunzo, Rosa Santacroce, Giovanna D'Andrea, et al.
Stem Cell Research
|
June 22, 2024
Generation of iPSC lines and isogenic gene-corrected lines from two individuals with RPS19-mutated Diamond-Blackfan anemia syndrome
Maria Angeles Lillo Osuna, Lei Han, Jon P Connelly, et al.
Veterinary Surgery : VS
|
December 14, 2023
Laparoscopic resection of pancreatic masses in 12 dogs
Edoardo Poggi, Felipe J Lillo-Araya, David Garcia Rubio, et al.
The Journal of Biological Chemistry
|
January 12, 2002
Structure and mechanism of 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase. An enzyme in the mevalonate-independent isoprenoid biosynthetic pathway
Stéphane B Richard, Jean-Luc Ferrer, Marianne E Bowman, et al.
Nature Structural Biology
|
June 28, 2001
Structure of 4-diphosphocytidyl-2-C- methylerythritol synthetase involved in mevalonate- independent isoprenoid biosynthesis
S B Richard, M E Bowman, W Kwiatkowski, et al.
AIDS Patient Care and Stds
|
October 15, 2009
Cardiovascular risk assessment in antiretroviral-naïve HIV patients
Paolo Maggi, Tiziana Quirino, Elena Ricci, et al.
Cancer Chemotherapy and Pharmacology
|
May 19, 2011
Population pharmacokinetics of PM00104 (Zalypsis(®)) in cancer patients
Carlos Pérez-Ruixo, Belén Valenzuela, Carlos Fernández Teruel, et al.
Investigational New Drugs
|
May 8, 2015
First-in-human, phase I study of elisidepsin (PM02734) administered as a 30-min or as a 3-hour intravenous infusion every three weeks in patients with advanced solid tumors
Mark J Ratain, David Geary, Samir D Undevia, et al.
Page
of 178